Cara Therapeutics, Inc. carries a market capitalization of 24.33M, placing it among publicly traded companies globally.
| Market Cap | 24.33M |
| Enterprise Value | N/A |
Cara Therapeutics, Inc.'s stock has gained approximately 359.48276% over the past 52 weeks. The 50-day moving average sits at 0.69, while the 200-day moving average is 1.89.
| Beta (5Y) | N/A |
| 52-Week Price Change | 359.48276% |
| 50-Day Moving Average | 0.69 |
| 200-Day Moving Average | 1.89 |
| Average Volume (20 Days) | N/A |
Cara Therapeutics, Inc.'s most recent stock split took place on December 31, 2024 with a 1000000:83333 split ratio.
| Last Split Date | 12/31/2024 |
| Split Ratio | 1000000:83333 |